UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
by Kim Yun-mi
2020-09-03 14:50
‘Cyramza helped improve gastric cancer treatment in Korea’
by Kim Yun-mi
2020-09-03 14:49
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
by Kim Yun-mi
2020-09-02 16:33
AZ requests court to nullify Dong-A ST’s avoidance of Forxiga patent
by Kim Yun-mi
2020-09-01 15:40
Doctors force drug sales reps to support ongoing strike
by Kim Yun-mi
2020-09-01 11:24
라인
‘Korea should introduce indication-specific drug pricing’
by Kim Yun-mi
2020-08-31 15:28
Korea publishes guidelines for digital therapeutics
by Kim Yun-mi
2020-08-27 18:05
Drugmakers to sue government for limiting choline alfoscerate benefit
by Kim Yun-mi
2020-08-27 14:26
Novartis fails trial on skin cancer drug candidate spartalizumab
by Kim Yun-mi
2020-08-26 11:11
Drug sales reps refrain from visiting doctors amid Covid-19 resurge
by Kim Yun-mi
2020-08-21 16:00
라인
‘Metastatic pancreatic cancer needs insurance benefit for Onyvide+5-FU/LV’
by Kim Yun-mi
2020-08-21 15:21
MSD Korea’s spinoff Organon Korea to settle in Gwanghwamun
by Kim Yun-mi
2020-08-18 11:39
‘NSAIDs after myocardial infarction raise bleeding risk’
by Kim Yun-mi
2020-07-28 16:17
AZ’s 3-in-1 inhaler for COPD to compete with GSK’s Trelegy
by Kim Yun-mi
2020-07-27 15:09
‘Tecentriq plus chemo can double survival in triple-negative breast cancer’
by Kim Yun-mi
2020-07-24 16:04
라인
Prosecutors raid GSK Korea’s vaccine division
by Kim Yun-mi
2020-07-23 11:04
‘Stage-3 unresectable lung cancer patient has every reason to use Imfinzi’
by Kim Yun-mi
2020-07-16 14:37
Biogen, Esai to test another Alzheimer’s drug in phase-3 study
by Kim Yun-mi
2020-07-15 12:42
‘Remdesivir cut death risk by 62% in severely ill Covid-19 patients’
by Kim Yun-mi
2020-07-13 14:44
Multinational drugmakers seek to form new trade union
by Kim Yun-mi
2020-07-13 11:44
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top